UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Reducing taxes on retirement income is crucial for financial health. Explore effective methods to retain more of your earnings.
20,007 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
As e.l.f. Beauty moves into 2026, investors want clarity on growth drivers and risk. This guide breaks down the Q4 ou...
A hedge fund warns that a toxic cocktail of rising inflation and undercompensated bond yields could push the S&P 500 ...
After a dramatic surge, investors want to know if Iren stock still after the rally makes sense. This article breaks d...
Mortgage demand dropped sharply in the latest MBA survey, with refinances leading the decline as rates trended higher...
A leading wealth manager just bought a notable position in a small-cap value ETF, highlighting renewed interest in ov...
New data show the richest workers who stay put often secure larger pay bumps than those who switch jobs in 2026, sign...
A celebrity-backed beverage launch sparked a broader lesson in money management. This piece breaks down how holland’s...
As Pure Cycle reports Q2 2026 results, investors weigh margins, guidance, and growth catalysts. This deep dive transl...
Medtronic stock popped today after the company topped earnings expectations and revenue forecasts. This article expla...
Interpreting the bbcp 2026 earnings transcript reveals how BBCP is growing, where margins are headed, and what to exp...
A volatile oil backdrop in mid-2026 is creating a rare entry point for Exxon Mobil. With disciplined costs and robust...